Patient Safety and Risk Management

PS-102

CAN THE PATIENT BRING MEDICINE TO THE HOSPITAL? - THE USE AND RISK OF BROUGHT IN MEDICINES

PS-101

RISK MANAGEMENT OF HBV REACTIVATION IN HAEMATOLOGICAL PATIENTS TREATED WITH RITUXIMAB

PS-100

VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS FOR HOSPITALIZED MEDICAL PATIENTS (HMP) WITH LOW MOLECULAR WEIGHT HEPARIN (LMWH)

PS-099

DRUG-DRUG INTERACTIONS IN FLUOROPYRIMIDINES-BASED REGIMENS USED IN COLORECTAL CANCER TREATMENT

PS-098

ROLE OF THE PHARMACIST IN THE IMPLEMENTATION OF A COMPREHENSIVE SAFETY PROGRAM

PS-097

ADMISSIONS CAUSED BY IATROGENIC DISEASE IN A REFERENCE HOSPITAL

PS-096

DENOSUMAB-INDUCED HYPOCALCEMIA IN PATIENTS WITH METASTATIC BONE DISEASE

PS-095

DRUG INTERACTIONS BETWEEN IMATINIB AND THE USUAL HOME TREATMENT

PS-094

BISPHOSPHONATE TREATMENT AND ATYPICAL FRACTURES

PS-093

PHARMACEUTICAL INTERVENTION TO PREVENT METFORMIN-ASSOCIATED LACTIC ACIDOSIS IN DIABETICS ADMITTED WITH KIDNEY FAILURE

PS-092

EVALUATION OF PATIENT SAFETY CULTURE AMONG HEALTHCARE PROFESSIONALS IN A PHARMACY DEPARTMENT

PS-091

BENEFITS OF MEDICINES RECONCILIATION IN AN EMERGENCY UNIT

PS-090

RESULTS OF A MEDICINES RECONCILIATION PROGRAM IN COMPLEX CHRONIC PATIENTS AT HOSPITAL DISCHARGE

PS-089

IMPLANTATION OF A SAFETY STRATEGY FOR DRUG STORAGE IN A PHARMACY SERVICE

PS-087

MEDICINES RECONCILIATION AT HOSPITAL DISCHARGE

Pages